Mohs Surgery
This is a preview of restricted content.
- If you are an Advisory Board member, please log in.
- If you are logged in and still see this message, the content is outside your memberships portfolio, and we invite you to learn more by contacting us.
- If you are not an Advisory Board member and wish to learn more, please contact us.
Topics: Service Lines, Technology Assessment, Planning, Strategy, Technology Assessment, Methodologies, Performance Improvement, Interventional Oncology, Oncology, Surgical Oncology
What is it?
Mohs Micrographic Surgery (MMS) is used primarily to enable complete tumor resection with removal of less healthy skin and tissue than traditional surgical excision (TSE). Accordingly, it is most commonly used to treat skin cancers located in critical and high-visibility areas, including the face, head and neck, hands, feet, and genitals, areas for which wide excision is either not an option due to interference with critical structures or highly undesirable for cosmetic reasons.
How does it work?
Using an iterative process, the Mohs surgeon removes layers of the tumor and performs a histological examination of each sample immediately following excision in order to determine if cancerous tissue has been left behind.
What problem does it solve?
For less aggressive tumors (basal cell and squamous cell carcinoma) in close proximity to critical structures, Mohs surgery enables the surgeon to minimize margins, optimize cosmetic outcomes, and achieve comparable (or better) results as TSE.
 Download PDF
